{
    "nctId": "NCT02781610",
    "officialTitle": "Standardized Treatment of Pulmonary Exacerbations II (STOP2)",
    "inclusionCriteria": "Key Inclusion Criteria:\n\n* Male or female \u226518 years of age at Visit 1\n* Documentation of a CF diagnosis\n* Enrolled in the Cystic Fibrosis Foundation National Patient Registry (CFFNPR) prior to Visit 1 (US sites only)\n* At the time of Visit 1, there is a plan to initiate IV antibiotics for a pulmonary exacerbation\n* Performed spirometry at Visit 1 and Visit 2 and willing to perform spirometry at Visit 3\n* Completed the CRISS questionnaire at Visit 1 and Visit 2 and willing to complete the Cystic Fibrosis Respiratory Symptoms Diary (CFRSD) questionnaire at Visit 3\n* Willing to adhere to a specific treatment duration determined by initial response to treatment and subsequent randomization\n* Willing to return for follow up Visit 3\n* Written informed consent obtained from the subject or subject's legal representative\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "Key Exclusion Criteria\n\n* Previous randomization in this study\n* Treatment with IV antibiotics in the 6 weeks prior to Visit 1\n* Admission to the intensive care unit for current pulmonary exacerbation in the two weeks prior to Visit 2, unless admission was due to a desensitization protocol\n* Pneumothorax in the two weeks prior to Visit 2\n* Primary diagnosis for current hospitalization is unrelated to worsening lower respiratory symptoms (e.g., pulmonary clean out, distal intestinal obstruction syndrome (DIOS), sinusitis)\n* Massive hemoptysis defined as \\> 250 cc in a 24 hour period or 100 cc/day over 4 consecutive days occurring in the two weeks prior to Visit 2\n* Current pulmonary exacerbation thought to be due to allergic bronchopulmonary aspergillosis (ABPA)\n* At Visit 1, receiving ongoing treatment with a duration of more than 2 weeks with prednisone equivalent to \\>10mg/day\n* History of solid organ transplantation\n* Receiving antimicrobial therapy to treat non-tuberculous mycobacterium (e.g., M. abscessus, M. avium complex) in the two weeks prior to Visit 2"
}